What precautions are necessary for anticoagulant use in patients with refractory thrombocytopenia, and how can risks be mitigated?
Gaurav ChauhanContributor
What are the considerations for anticoagulant use in patients with refractory thrombocytopenia?
Share
Anticoagulant use in patients with refractory thrombocytopenia requires careful monitoring of platelet counts and coagulation parameters to mitigate bleeding risks. Adjusting doses and using platelet transfusions can help manage these risks.